EUVIMEDEUVIMED entdecken
Crossref

Identification of HIV-1 Integrase Inhibitors Based on a Four-Point Pharmacophore

H Hong, N Neamati, H E Winslow, J L Christensen, A Orr, Y Pommier, G W Milne

Antiviral Chemistry and Chemotherapy · 1998-12 · 9 (6) · 461-472

DOI: 10.1177/095632029800900602 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antiviral Chemistry and Chemotherapy, online erschienen am 01.12.1998. Verfasst von H Hong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medicinal Chemistry, National Cancer Institute, National Institutes of Health, MD 20892, USA. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rapid emergence of human immunodeficiency virus (HIV) strains resistant to available drugs implies that effective treatment modalities will require the use of a combination of drugs targeting different sites of the HIV life cycle. Because the virus cannot replicate without integration into a host chromosome, HIV-1 integrase (IN) is an attractive therapeutic target. Thus, an effective IN inhibitor should provide additional benefit in combination chemotherapy. A four-point pharmacophore has been identified based on the structures of quinalizarin and purpurin, which were found to be potent IN inhibitors using both a preintegration complex assay and a purified enzyme assay in vitro. Searching with this four-point pharmacophore in the ‘open” part of the National Cancer Institute three-dimensional structure database produced 234 compounds containing the pharmacophore. Sixty of these compounds were tested for their inhibitory activity against IN using the purified enzyme; 19 were found to be active against IN with IC 50 values of less than 100 µM, among which 10 had IC 50 values of less than 10 µM. These inhibitors can further serve as leads, and studies are in progress to design novel inhibitors based on the results presented in this study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnthraquinonesAnti-HIV AgentsCell LineDatabases, FactualDrug DesignDrug Evaluation, PreclinicalHIV IntegraseHIV Integrase InhibitorsHIV-1HumansLymphocytesMolecular StructureStructure-Activity RelationshipVirus Integration

Substanzen

AnthraquinonesAnti-HIV AgentsHIV Integrase InhibitorsHIV Integrase

Autor:innen und Institutionen

  • Laboratory of Medicinal Chemistry, National Cancer Institute, National Institutes of Health, MD 20892, USA.

Zitieren

APA

Hong, H., Neamati, N., Winslow, H. E., Christensen, J. L., Orr, A., Pommier, Y., & Milne, G. W. (1998). Identification of HIV-1 Integrase Inhibitors Based on a Four-Point Pharmacophore. Antiviral Chemistry and Chemotherapy, 9(6), 461-472. https://doi.org/10.1177/095632029800900602

Vancouver

Hong H, Neamati N, Winslow HE, Christensen JL, Orr A, Pommier Y, et al. Identification of HIV-1 Integrase Inhibitors Based on a Four-Point Pharmacophore. Antiviral Chemistry and Chemotherapy. 1998;9(6):461-472. doi:10.1177/095632029800900602

BibTeX
@article{Hong1998,
  author = {Hong, H and Neamati, N and Winslow, H E and Christensen, J L and Orr, A and Pommier, Y and Milne, G W},
  title = {Identification of HIV-1 Integrase Inhibitors Based on a Four-Point Pharmacophore},
  journal = {Antiviral Chemistry and Chemotherapy},
  year = {1998},
  volume = {9},
  number = {6},
  pages = {461--472},
  doi = {10.1177/095632029800900602}
}
Kostenlos starten →